ArticleOncology letters2016

Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer.

Rei Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.